• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[植入式心脏复律除颤器在心脏性猝死一级和二级预防患者中的抗心律失常干预措施]

[Antitachyarrhythmic interventions of implantable cardioverter-defibrillator in primary and secondary sudden cardiac death prevention patients].

作者信息

Piekarz Justyna, Rydlewska Anna, Majewski Jacek, Lelakowski Jacek

机构信息

Jagiellonian University, School of Medicine, Cracow, Poland, Institute of Cardiology, Department of Electrocardiology, The John Paul II Hospital in Krakow, Poland.

出版信息

Pol Merkur Lekarski. 2012 Jun;32(192):368-73.

PMID:22891561
Abstract

UNLABELLED

Antitachycardia pacing (ATP) and high voltage interventions (CV) are methods of interrupting dangerous ventricular arrhythmias. The aim of the study was to determine the frequency of ventricular tachyarrhythmias and form of ICD interventions in patients in the primary and secondary sudden cardiac death (SCD) prevention groups.

MATERIAL AND METHODS

The study involved 399 patients (334 male, 65 female), mean age was 65.2 +/- 12.1 years (21-89 years), who had an ICD implanted in years 2008-2010. The analysis comprised age, gender, indications for ICD implantation, intracardiac electrograms derived from ICD during the follow-up.

RESULTS

The patients were divided in 2 groups depending on the SCD prevention type: group A - primary prevention, group B - secondary prevention. In the A group, the peak death rate was in the 7th decade of life, while in the B group it was 10 years later. In the A group the main condition was coronary arteries disease (CAD) (76%) and dilating non-ischemic cardiomiopathy (18%), whilst in the B group, only CAD (100%). In the A group different forms of ventricular tachyarrhythmias were registered more often in the dead (57%), than living patients (38%). The difference was statistically significant (p < 0.025) and considered mainly ventricular fibrillation observed in 21% of dead patients and only in 4,2% living. Despite the fact, that in the B group the percentage of dangerous ventricular tachyarrhythmias (VT and especially VF) was higher, there were fewer deaths than in A group (7.8 vs 12.8%). In living patients in the B group, there were registered twice as many ICD interventions as in the A group. In the A group, in patients over 70 years old, in contrary to the younger, more frequently ventricular tachyarrhythmias and antiarrhythmic interventions (ATP, CV) were observed. In the B group, the relation was reversed. Inadequate and ineffective interventions occurred mainly in the A group.

CONCLUSIONS

There were twice as many ICD interventions in patients implanted in secondary SCD prevention than in patients implanted in primary prevention. In secondary prevention, in contrary to the primary, the frequency of ventricular tachyarrhythmias and ICD interventions in patients younger than 70 years old is higher than in older patients. The most frequent reason for inadequate ICD interventions are sinus tachycardia and atrial fibrillation.

摘要

未标记

抗心动过速起搏(ATP)和高电压干预(CV)是中断危险室性心律失常的方法。本研究的目的是确定一级和二级心脏性猝死(SCD)预防组患者室性快速心律失常的发生率以及植入式心律转复除颤器(ICD)干预的形式。

材料与方法

本研究纳入了399例患者(男性334例,女性65例),平均年龄为65.2±12.1岁(21 - 89岁),他们于2008 - 2010年植入了ICD。分析内容包括年龄、性别、ICD植入指征以及随访期间从ICD获取的心内电图。

结果

根据SCD预防类型将患者分为两组:A组 - 一级预防,B组 - 二级预防。在A组中,死亡率高峰出现在70岁年龄段,而在B组中则晚10年。在A组中,主要疾病是冠状动脉疾病(CAD)(76%)和扩张型非缺血性心肌病(18%),而在B组中,仅CAD(100%)。在A组中,不同形式的室性快速心律失常在死亡患者中出现的频率(57%)高于存活患者(38%)。差异具有统计学意义(p < 0.025),主要是因为在21%的死亡患者中观察到心室颤动,而存活患者中仅为4.2%。尽管B组中危险室性快速心律失常(室性心动过速,尤其是心室颤动)的百分比更高,但死亡人数比A组少(7.8%对12.8%)。在B组的存活患者中,ICD干预的次数是A组的两倍。在A组中,70岁以上患者与年轻患者相比,更频繁地出现室性快速心律失常和抗心律失常干预(ATP,CV)。在B组中,这种关系相反。不适当和无效的干预主要发生在A组。

结论

二级SCD预防植入患者的ICD干预次数是一级预防植入患者的两倍。在二级预防中,与一级预防相反,70岁以下患者室性快速心律失常和ICD干预的频率高于老年患者。ICD干预不适当的最常见原因是窦性心动过速和心房颤动。

相似文献

1
[Antitachyarrhythmic interventions of implantable cardioverter-defibrillator in primary and secondary sudden cardiac death prevention patients].[植入式心脏复律除颤器在心脏性猝死一级和二级预防患者中的抗心律失常干预措施]
Pol Merkur Lekarski. 2012 Jun;32(192):368-73.
2
Factors predisposing to ventricular tachyarrhythmia leading to appropriate ICD intervention in patients with coronary artery disease or non-ischaemic dilated cardiomyopathy.导致冠心病或非缺血性扩张型心肌病患者 ICD 干预的致室性心律失常的相关因素。
Kardiol Pol. 2012;70(12):1264-75.
3
Determinants of patient survival rate after implantation of a cardioverter-defibrillator without resynchronisation capability.无再同步功能的心脏除颤器植入后患者生存率的决定因素。
Kardiol Pol. 2012;70(11):1099-110.
4
Efficacy and safety of celivarone, with amiodarone as calibrator, in patients with an implantable cardioverter-defibrillator for prevention of implantable cardioverter-defibrillator interventions or death: the ALPHEE study.以胺碘酮为校准剂的塞利伐酮在植入式心脏复律除颤器患者中预防植入式心脏复律除颤器干预或死亡的疗效和安全性:ALPHEE 研究。
Circulation. 2011 Dec 13;124(24):2649-60. doi: 10.1161/CIRCULATIONAHA.111.072561. Epub 2011 Nov 14.
5
Ventricular tachyarrhythmia recurrence in primary versus secondary implantable cardioverter-defibrillator patients and role of electrophysiology study.原发性与继发性植入式心脏复律除颤器患者室性快速性心律失常复发情况及电生理检查的作用
J Interv Card Electrophysiol. 2014 Dec;41(3):195-202. doi: 10.1007/s10840-014-9941-8. Epub 2014 Sep 30.
6
Ventricular tachyarrhythmias in patients receiving an implantable cardioverter-defibrillator for primary versus secondary prophylaxis indications.接受植入式心脏复律除颤器进行一级与二级预防指征治疗的患者的室性快速心律失常。
Pacing Clin Electrophysiol. 2011 May;34(5):571-6. doi: 10.1111/j.1540-8159.2010.03004.x. Epub 2011 Jan 5.
7
Clinical course and prognostic relevance of antitachycardia pacing-terminated ventricular tachyarrhythmias in implantable cardioverter-defibrillator patients.植入式心脏复律除颤器患者中抗心动过速起搏终止的室性心律失常的临床过程和预后相关性。
Europace. 2015 Jul;17(7):1068-75. doi: 10.1093/europace/euv007. Epub 2015 Feb 16.
8
[Factors predisposing to the reprogramming of implantable cardioverter-defibrillators and the causes of changes in pharmacotherapy in patients with dilated cardiomyopathy for primary prevention of sudden cardiac death].[扩张型心肌病患者植入式心律转复除颤器重新编程的诱发因素及心脏性猝死一级预防中药物治疗变化的原因]
Pol Merkur Lekarski. 2015 Aug;39(230):86-90.
9
Left intraventricular pressure gradient in hypertrophic cardiomyopathy patients receiving implantable cardioverter-defibrillators for primary prevention.肥厚型心肌病患者接受植入式心脏复律除颤器一级预防后左室内压力梯度。
BMC Cardiovasc Disord. 2021 Feb 19;21(1):106. doi: 10.1186/s12872-021-01910-0.
10
[Negative result of microvolt T-wave alternans test is helpful in scheduling the order of cardioverter-defibrillator implantation in primary prevention of sudden cardiac death in individuals with the left ventricular systolic dysfunction].[微伏级T波交替试验阴性结果有助于安排左心室收缩功能障碍患者心脏性猝死一级预防中植入心脏复律除颤器的顺序]
Pol Merkur Lekarski. 2012 Oct;33(196):193-7.